Neuroimaging Findings in Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations

References

1. 1.↵
   1. Richards A,
   2. van den Maagdenberg AM,
   3. Jen JC, et al

   . C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet 2007;39:1068–70 doi:10.1038/ng2082 pmid:17660820

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Jen J,
   2. Cohen AH,
   3. Yue Q, et al

   . Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology 1997;49:1322–30 doi:10.1212/WNL.49.5.1322 pmid:9371916

   CrossRefPubMed
3. 3.↵
   1. Kolar GR,
   2. Kothari PH,
   3. Khanlou N, et al

   . Neuropathology and genetics of cerebroretinal vasculopathies. Brain Pathol 2014;24:510–18 doi:10.1111/bpa.12178 pmid:25323666

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Pelzer N,
   2. Hoogeveen ES,
   3. Haan J, et al

   . Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease. J Intern Med 2019;285:317–13 doi:10.1111/joim.12848 pmid:30411414

   CrossRefPubMed
5. 5.↵
   1. Dhamija R,
   2. Schiff D,
   3. Lopes MB, et al

   . Evolution of brain lesions in a patient with TREX1 cerebroretinal vasculopathy. Neurology 2015;85:1633–34 doi:10.1212/WNL.0000000000002092 pmid:26527794

   Abstract/FREE Full Text
6. 6.↵
   1. Terwindt GM,
   2. Haan J,
   3. Ophoff RA, et al

   . Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud’s phenomenon. Brain 1998;121:303–16 doi:10.1093/brain/121.2.303 pmid:9549508

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Weil S,
   2. Reifenberger G,
   3. Dudel C, et al

   . Cerebroretinal vasculopathy mimicking a brain tumor: a case of a rare hereditary syndrome. Neurology 1999;53:629–31 doi:10.1212/WNL.53.3.629 pmid:10449133

   Abstract/FREE Full Text
8. 8.↵
   1. Mateen FJ,
   2. Krecke K,
   3. Younge BR, et al

   . Evolution of a tumor-like lesion in cerebroretinal vasculopathy and TREX1 mutation. Neurology 2010;75:1211–13 doi:10.1212/WNL.0b013e3181f4d7ac pmid:20876473

   FREE Full Text
9. 9.↵
   1. Stam AH,
   2. Kothari PH,
   3. Shaikh A, et al

   . Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. Brain 2016;139:2909–22 doi:10.1093/brain/aww217 pmid:27604306

   CrossRefPubMed
10. 10.↵
    1. Monroy-Jaramillo N,
    2. Ceron A,
    3. Leon E, et al

    . Phenotypic variability in a Mexican Mestizo family with retinal vasculopathy with cerebral leukodystrophy and TREX1 mutation p.V235Gfs*6. Rev Invest Clin 2018;70:68–75 doi:10.24875/RIC.18002492 pmid:29718010

    CrossRefPubMed
11. 11.↵
    1. Hardy TA,
    2. Young S,
    3. Sy JS, et al

    . Tumefactive lesions in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S): a role for neuroinflammation? J Neurol Neurosurg Psychiatry 2018;89:434–35 doi:10.1136/jnnp-2017-316142

    FREE Full Text
12. 12.↵
    1. Carra-Dalliere C,
    2. Ayrignac X,
    3. Prieto-Morin C, et al

    . TREX1 mutation in leukodystrophy with calcifications and persistent gadolinium-enhancement. Eur Neurol 2017;77:113–14 doi:10.1159/000455095 pmid:28013302

    CrossRefPubMed
13. 13.↵
    1. Gutmann DH,
    2. Fischbeck KH,
    3. Sergott RC

    . Hereditary retinal vasculopathy with cerebral white matter lesions. Am J Med Genet 1989;34:217–20 doi:10.1002/ajmg.1320340217 pmid:2817001

    CrossRefPubMed
14. 14.↵
    1. Grand MG,
    2. Kaine J,
    3. Fulling K, et al

    . Cerebroretinal vasculopathy: a new hereditary syndrome. Ophthalmology 1988;95:649–59 doi:10.1016/S0161-6420(88)33131-3 pmid:3174024

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Raynowska J,
    2. Miskin DP,
    3. Pramanik B, et al

    . Retinal vasculopathy with cerebral leukoencephalopathy (RVCL): a rare mimic of tumefactive MS. Neurology 2018;91:e1423–28 doi:10.1212/WNL.0000000000006329 pmid:30194247

    Abstract/FREE Full Text
16. 16.↵
    1. Hedderich DM,
    2. Lummel N,
    3. Deschauer M, et al

    . Magnetic resonance imaging characteristics of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. Clin Neuroradiol 2020;30:229–36 doi:10.1007/s00062-018-0755-4 pmid:30627749

    CrossRefPubMed
17. 17.↵
    1. Ford AL,
    2. Chin VW,
    3. Fellah S, et al

    . Lesion evolution and neurodegeneration in RVCL-S: a monogenic microvasculopathy. Neurology 2020;95:e1918–31 doi:10.1212/WNL.0000000000010659 pmid:32887784

    Abstract/FREE Full Text
18. 18.↵
    1. Saito R,
    2. Nozaki H,
    3. Kato T, et al

    . Retinal vasculopathy with cerebral leukodystrophy: clinicopathologic features of an autopsied patient with a heterozygous TREX 1 mutation. J Neuropathol Exp Neurol 2019;78:181–86 doi:10.1093/jnen/nly115

    CrossRef